INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $456,000 | +26.7% | 98,679 | -4.1% | 0.00% | – |
Q4 2018 | $360,000 | -53.7% | 102,920 | +33.5% | 0.00% | – |
Q3 2018 | $778,000 | +88.4% | 77,101 | +35.3% | 0.00% | – |
Q2 2018 | $413,000 | +25.5% | 57,001 | +4.7% | 0.00% | – |
Q1 2018 | $329,000 | -40.1% | 54,464 | -4.5% | 0.00% | – |
Q4 2017 | $549,000 | +49.2% | 57,020 | +37.3% | 0.00% | – |
Q3 2017 | $368,000 | +5.1% | 41,516 | +50.1% | 0.00% | – |
Q2 2017 | $350,000 | +21.1% | 27,667 | +0.5% | 0.00% | – |
Q1 2017 | $289,000 | +48.2% | 27,541 | +30.3% | 0.00% | – |
Q4 2016 | $195,000 | -24.7% | 21,134 | -3.9% | 0.00% | – |
Q3 2016 | $259,000 | -14.2% | 21,985 | -5.9% | 0.00% | – |
Q2 2016 | $302,000 | -26.9% | 23,362 | -9.6% | 0.00% | – |
Q1 2016 | $413,000 | -46.4% | 25,829 | -3.9% | 0.00% | – |
Q4 2015 | $770,000 | -96.8% | 26,878 | -96.8% | 0.00% | -100.0% |
Q3 2015 | $23,893,000 | +359.7% | 839,525 | +480.3% | 0.01% | +400.0% |
Q2 2015 | $5,197,000 | -72.1% | 144,661 | -54.8% | 0.00% | -50.0% |
Q1 2015 | $18,606,000 | +152.2% | 320,134 | +83.0% | 0.00% | +33.3% |
Q4 2014 | $7,377,000 | +68.9% | 174,953 | +55.3% | 0.00% | +50.0% |
Q3 2014 | $4,368,000 | +42.0% | 112,637 | +14.3% | 0.00% | +100.0% |
Q2 2014 | $3,077,000 | -34.3% | 98,519 | -12.8% | 0.00% | -50.0% |
Q1 2014 | $4,681,000 | +82.2% | 112,993 | +70.2% | 0.00% | +100.0% |
Q4 2013 | $2,569,000 | -29.6% | 66,381 | -36.3% | 0.00% | -50.0% |
Q3 2013 | $3,648,000 | +13.5% | 104,247 | -55.1% | 0.00% | 0.0% |
Q2 2013 | $3,213,000 | – | 232,188 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |